AI-generated summary
This narrative review summarizes intranasal photobiomodulation therapy, including nostril-based devices and simulated deep-nasal light delivery methods. The authors report that nostril-based treatment has been associated with improved blood rheology and cerebral blood flow, and that several brain conditions have been studied with it. They note that deep-nasal implantation has not been tested clinically, and that comparative studies including sham and transcranial treatment are still needed.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a narrative review, and the authors state that deep-nasal delivery has only been examined in simulation studies and that comparative trials are still needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on degruyter.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Intranasal photobiomodulation, Mild cognitive impairment, Light-emitting diode, Cerebral blood flow, Depression, Insomnia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.